These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19447208)

  • 81. PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
    Khan I; Gothwal A; Sharma AK; Kesharwani P; Gupta L; Iyer AK; Gupta U
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):159-93. PubMed ID: 27651101
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Nucleic Acid-Based Functional Nanomaterials as Advanced Cancer Therapeutics.
    Yuan Y; Gu Z; Yao C; Luo D; Yang D
    Small; 2019 Jun; 15(26):e1900172. PubMed ID: 30972963
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Nanoscale drug carriers for traditional Chinese medicine research and development].
    Yi CX; Yu JN; Xu XM
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.
    Chenel V; Boissy P; Poirier MS; Cloarec JP; Patenaude J
    Int J Nanomedicine; 2015; 10():2125-37; quiz 2138-9. PubMed ID: 25844040
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers - I: formulation, lyoavailability and in vitro antimalarial activity assessment.
    Yaméogo JB; Gèze A; Choisnard L; Putaux JL; Gansané A; Sirima SB; Semdé R; Wouessidjewe D
    Eur J Pharm Biopharm; 2012 Apr; 80(3):508-17. PubMed ID: 22226681
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
    Formica ML; Calles JA; Palma SD
    Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Advances in novel drug delivery strategies for breast cancer therapy.
    Dhankhar R; Vyas SP; Jain AK; Arora S; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Oct; 38(5):230-49. PubMed ID: 20677900
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern.
    Akhter S; Ahmad Z; Singh A; Ahmad I; Rahman M; Anwar M; Jain GK; Ahmad FJ; Khar RK
    Curr Pharm Des; 2011; 17(18):1834-50. PubMed ID: 21568874
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Targeted Drug Delivery for Sustainable Crop Protection: Transport and Stability of Polymeric Nanocarriers in Plants.
    Beckers SJ; Staal AHJ; Rosenauer C; Srinivas M; Landfester K; Wurm FR
    Adv Sci (Weinh); 2021 Jun; 8(11):e2100067. PubMed ID: 34105269
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Advancements in liposomal formulations: A comprehensive exploration of industrial production techniques.
    Sameer Khan M; Gupta G; Alsayari A; Wahab S; Sahebkar A; Kesharwani P
    Int J Pharm; 2024 Jun; 658():124212. PubMed ID: 38723730
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
    Mitragotri S; Burke PA; Langer R
    Nat Rev Drug Discov; 2014 Sep; 13(9):655-72. PubMed ID: 25103255
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Magnetically-activated lipid nanocarriers in biomedical applications: A review of current status and perspective.
    Sun X; Tan A; Boyd BJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1863. PubMed ID: 36428234
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nanosponge Approach -A Plethora of Opportunities as a Promising Nanocarrier for Novel Drug Delivery.
    Bhavin SE; Anuradha G
    Recent Pat Nanotechnol; 2022; 16(4):271-282. PubMed ID: 34303335
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Self-assembling nanocarriers from engineered proteins: Design, functionalization, and application for drug delivery.
    Li Y; Champion JA
    Adv Drug Deliv Rev; 2022 Oct; 189():114462. PubMed ID: 35934126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.